NM_001194958.2:c.1061C>T
Variant names:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 2P and 8B. PM1BP4_StrongBS2
The NM_001194958.2(KCNJ18):c.1061C>T(p.Thr354Met) variant causes a missense change. The variant allele was found at a frequency of 0.00029 in 1,611,970 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as risk factor (no stars).
Frequency
Genomes: 𝑓 0.0015 ( 0 hom., cov: 35)
Exomes 𝑓: 0.00016 ( 0 hom. )
Consequence
KCNJ18
NM_001194958.2 missense
NM_001194958.2 missense
Scores
8
5
3
Clinical Significance
Conservation
PhyloP100: 6.57
Genes affected
KCNJ18 (HGNC:39080): (potassium inwardly rectifying channel subfamily J member 18) This gene encodes a member of the inwardly rectifying potassium channel family. Transcription of this locus is regulated by thyroid hormone, and the encoded protein plays a role in resting membrane potential maintenance. Mutations in this locus have been associated with thyrotoxic hypokalemic periodic paralysis. [provided by RefSeq, Jan 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
PM1
In a mutagenesis_site Decreases the single-channel open probability (Po) without altering its conductance. (size 0) in uniprot entity KCJ18_HUMAN
BP4
Computational evidence support a benign effect (MetaRNN=0.023779243).
BS2
High AC in GnomAd4 at 232 AD gene.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00148 AC: 226AN: 152240Hom.: 0 Cov.: 35
GnomAD3 genomes
AF:
AC:
226
AN:
152240
Hom.:
Cov.:
35
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000161 AC: 235AN: 1459612Hom.: 0 Cov.: 35 AF XY: 0.000128 AC XY: 93AN XY: 726112
GnomAD4 exome
AF:
AC:
235
AN:
1459612
Hom.:
Cov.:
35
AF XY:
AC XY:
93
AN XY:
726112
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00152 AC: 232AN: 152358Hom.: 0 Cov.: 35 AF XY: 0.00161 AC XY: 120AN XY: 74510
GnomAD4 genome
AF:
AC:
232
AN:
152358
Hom.:
Cov.:
35
AF XY:
AC XY:
120
AN XY:
74510
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
16
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
52
ClinVar
Significance: risk factor
Submissions summary: Other:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Thyrotoxic periodic paralysis, susceptibility to, 2 Other:1
Jan 08, 2010
OMIM
Significance: risk factor
Review Status: no assertion criteria provided
Collection Method: literature only
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DEOGEN2
Uncertain
D
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D
M_CAP
Uncertain
D
MetaRNN
Benign
T
MetaSVM
Pathogenic
D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D
Sift
Pathogenic
D
Sift4G
Uncertain
D
Vest4
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at